AI-Driven De Novo Generation of Protein Binders

Format:

AI-Driven De Novo Generation of Protein Binders

About the poster

This project aimed to leverage AI-driven methods, complemented by advanced computational techniques such as Molecular Modelling (MM) and Molecular Dynamics (MD) simulations, to generate novel binders for two prespecified protein targets: T1 and T2. The entire binder discovery process – from initial target analysis to final candidate selection – was performed in silico.

The core objective was to generate a ranked list of up to 100 binder candidates for each target through a comprehensive computational approach. This process encompasses the identification of promising binding sites, the design of novel binder structures and sequences using generative AI models, and rigorous in silico filtering and ranking based on predicted binding, stability, solubility, and other key biochemical properties. 

Poster was presented at PEGS 2026 in Boston

You might be also interested in:

Biomedical knowledge graph connecting drug discovery data, disease biology, targets and indications to support target prioritization and indication expansion
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Life sciences professional using a tablet in front of digital data infrastructure screens
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!